According to the 2016 WHO classification scheme, there were 19 (63.3%) IDH-wildtype GBM, 6 (20.0%) IDH-mutant GBM, and 5 (16.7%) H3K27M-mutant DMG. The gene discussed is IDH1; the disease is glioblastoma.